{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:24:49Z","timestamp":1790490289475,"version":"4.1.0"},"reference-count":138,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Cardiovascular Therapy"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1586\/14779072.6.4.447","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T05:44:17Z","timestamp":1207892657000},"page":"447-470","source":"Crossref","is-referenced-by-count":125,"title":["Ezetimibe: cholesterol lowering and beyond"],"prefix":"10.1586","volume":"6","author":[{"given":"Harold E","family":"Bays","sequence":"first","affiliation":[{"name":"Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Neff","sequence":"additional","affiliation":[{"name":"Merck & Co., N. Wales, PA 19454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E","family":"Tomassini","sequence":"additional","affiliation":[{"name":"Merck & Co., N. Wales, PA 19454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M","family":"Tershakovec","sequence":"additional","affiliation":[{"name":"Merck & Co., N. Wales, PA 19454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.3.5.789"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.085"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.11.11.1587"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.4.4.461"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.15.11.1337"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.10.006"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-200306000-00002"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.5.779"},{"key":"e_1_3_2_13_1","unstructured":"Mayes PA. Cholesterol synthesis transport and excretion. In: Harper\u2019s Biochemistry (25th Edition). Murray RK Granner DK Mayes PA Rodwell VW (Eds). Appleton & Lange CT USA 285\u2013305 (2000)."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)35728-X"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000170946.56981.5c"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00022.2005"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00351.x"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i40.6429"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/87170"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.69.031905.160725"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5497.1771"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X167660"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116766.31036.03"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0216001"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.10.006"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27352"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)50321-5"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M405817200"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500269102"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2004.11.017"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2007.00534.x"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30060"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00825-1"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.11.1901"},{"key":"e_1_3_2_35_1","first-page":"186","volume":"102","author":"Davis","year":"2000","unstructured":"Davis HR, Compton DS, Hoos LM, Tetzloff GG. Ezetimibe reduces plasma cholesterol and inhibits the development of atherosclerosis in apo E knockout mice with and without LDL receptors. Circulation102(18), 186 (2000).","journal-title":"Circulation"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400475-JLR200"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000216750.09611.ec"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666150-00005"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000018744.58460.62"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M700067-JLR200"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1042\/bst0310528"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800605774962086"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00054-0"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01229.x"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093131"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-006-0068-y"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600439-JLR200"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000034044.95911.DC"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80102-8"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02798-4"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00807-2"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1520-765X(01)90107-5"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070352"},{"key":"e_1_3_2_55_1","unstructured":"Zetia. Product insert. 2001."},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02774-1"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.4065\/80.5.587"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.011"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00289.x"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.4065\/79.5.620"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.059"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.060"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.048"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.10.021"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068312.21969.C8"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.016"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.023"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132721"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X2321"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2006.020"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.4065\/81.12.1579"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.174516"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000038419.53000.D6"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehjsup.2004.01.010"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.2217\/1745509X.3.6.691"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.s1.06.s4"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169405"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.1.189"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-006-0063-3"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200523915"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300350-JLR200"},{"key":"e_1_3_2_84_1","first-page":"437","volume":"1","author":"Taggart","year":"2007","unstructured":"Taggart W, Lutjohann D, Musliner T, Sudhop T, Shah A, von Bergmann K. Inhibition of intestinal cholesterol absorption and endogenous cholesterol production by ezetimibe\/simvastatin in man. J. Clin. Lipid.1(5), 437 (2007).","journal-title":"J. Clin. Lipid."},{"key":"e_1_3_2_85_1","first-page":"II159","volume":"116","author":"Briand","year":"2007","unstructured":"Briand F, Millar J, Billheimer J, Rothblat G, Rader D. Inhibition of cholesterol absorption with ezetimibe promotes macrophage to feces reverse cholesterol transport in mice. Circulation116, II159\u2013 II160 (2007).","journal-title":"Circulation"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.09.031"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01616.x"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.583336"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.08.006"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.532499"},{"key":"e_1_3_2_92_1","first-page":"921","volume":"169","author":"Genest","year":"2003","unstructured":"Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ169(9), 921\u2013924 (2003).","journal-title":"CMAJ"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.588178"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600353-JLR200"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021993"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042000"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042378"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.01.062"},{"key":"e_1_3_2_100_1","first-page":"466","volume":"1","author":"Pearson","year":"2007","unstructured":"Pearson T, Ballantyne CM, Veltri ER et al. CRP and D LDL-C response to ezetimibe: monotherapy and add-on to baseline statin. Triennial international symposium on drugs affecting lipid metabolism. J. Clin. Lipidol.1(5), 466 (2007).","journal-title":"J. Clin. Lipidol."},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.3.690"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.024"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.083"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000163840.63685.0c"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.06.092"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20229"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00484-6"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)32331-2"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000173310.85845.7b"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000125278.58527.F3"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.10.2474"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.043"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.526848"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000154144.73236.f4"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02427-X"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.2.495"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi231"},{"key":"e_1_3_2_118_1","first-page":"III143","volume":"110","author":"Tribble","year":"2004","unstructured":"Tribble D, Farnier M, Freeman MW et al. Effect of fenofibrate and ezetimibe on lipoprotein subclasses and LDL subclass pattern in patients with mixed hyperlipidemia. Circulation110(17, Suppl.), III143\u2013III144 (2004).","journal-title":"Circulation"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.10.004"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X188062"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945007780362809"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2006.tb00224.x"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568016043477323"},{"key":"e_1_3_2_124_1","first-page":"U892","volume":"112","author":"Matthan","year":"2005","unstructured":"Matthan N, Larocque JM, Pencina M et al. Increased cholesterol absorption and decreased cholesterol synthesis characterize Framingham Offspring Study participants with coronary heart disease. Circulation112(17 Suppl. S), U892\u2013U893 (2005).","journal-title":"Circulation"},{"key":"e_1_3_2_125_1","author":"Fassbender","year":"2006","unstructured":"Fassbender K, Lutjohann D, Dik MG et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-The LASA study. Atherosclerosis (doi:10.1016\/j.atherosclerosis.2006.10. 032) (2006).","journal-title":"Atherosclerosis"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600371-JLR200"},{"key":"e_1_3_2_127_1","first-page":"884","volume":"114","author":"Thiery","year":"2006","unstructured":"Thiery J, Ceglarek U, Fiedler G et al. Elevated campesterol serum levels \u2013 a significant predictor of incident myocardial infarction: Results of the population-based MONICA\/KORA follow-up study 1994 to 2005. Circulation114(18 Suppl. S), 884 (2006).","journal-title":"Circulation"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000149140.00499.92"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328011e9e3"},{"key":"e_1_3_2_130_1","first-page":"392A","volume":"45","author":"Sudhop","year":"2005","unstructured":"Sudhop T, Lutjohann D, Reber D et al. Inhibition of intestinal cholesterol absorption and endogenous cholesterol synthesis by ezetimibe\/simvastatin in humans. J. Am. Coll. Cardiol45(3 Suppl A), 392A (2005).","journal-title":"J. Am. Coll. Cardiol"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253663"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.1.361"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.3.708"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200266-JLR200"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600261-JLR200"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.06.024"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.10.064"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.4.x"},{"key":"e_1_3_2_139_1","author":"Cannon","year":"2007","unstructured":"Cannon CP, Guigliano RP, Blazing MA et al for the IMPROVE-IT investigators. Design and Rationale of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimibe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndrome. Am. Heart J. (2007). [Epub ahead of print].","journal-title":"Am. Heart J."},{"key":"e_1_3_2_140_2_1","unstructured":"Merck\/Schering-Plough Pharmaceuticals provides results of the ENHANCE Trial. www.merck.com\/newsroom\/press_releases\/product\/2008_0114.html"}],"container-title":["Expert Review of Cardiovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14779072.6.4.447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:20:49Z","timestamp":1772770849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14779072.6.4.447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1586\/14779072.6.4.447"],"URL":"https:\/\/doi.org\/10.1586\/14779072.6.4.447","relation":{},"ISSN":["1477-9072","1744-8344"],"issn-type":[{"value":"1477-9072","type":"print"},{"value":"1744-8344","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}